These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 3730622)

  • 41. Mechanism of defective NK cell activity in patients with acquired immunodeficiency syndrome (AIDS) and AIDS-related complex. II. Normal antibody-dependent cellular cytotoxicity (ADCC) mediated by effector cells defective in natural killer (NK) cytotoxicity.
    Katz JD; Mitsuyasu R; Gottlieb MS; Lebow LT; Bonavida B
    J Immunol; 1987 Jul; 139(1):55-60. PubMed ID: 3584988
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Measurement of NK activity by the microcytotoxicity assay (MCA): a new application for an old assay.
    Wahlberg BJ; Burholt DR; Kornblith P; Richards TJ; Bruffsky A; Herberman RB; Vujanovic NL
    J Immunol Methods; 2001 Jul; 253(1-2):69-81. PubMed ID: 11384670
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Development of lymphoproliferative disorder of granular lymphocytes in association with hairy cell leukemia.
    Xie XY; Sorbara L; Kreitman RJ; Fukushima PI; Kingma DW; Stetler-Stevenson M
    Leuk Lymphoma; 2000 Mar; 37(1-2):97-104. PubMed ID: 10721773
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Application of non-radioactive europium (Eu3+) release assay to a measurement of human natural killer activity of healthy and patient populations.
    Nagao F; Yabe T; Xu M; Yokoyama K; Saito K; Okumura K
    Immunol Invest; 1996; 25(5-6):507-18. PubMed ID: 8915687
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Enhancement of human lymphocyte natural killer activity by somatostatin.
    Pawlikowski M; Zelazowski P; Stepien H
    Neuropeptides; 1989; 13(2):75-7. PubMed ID: 2567973
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Effect of alpha-interferon on the immune system of patients with hairy cell leukemia.
    Foa R; Fierro MT; Lusso P; Bonferroni M; Raspadori D; Buzzi M; Zinzani PL; Resegotti L; Lauria F
    Leukemia; 1987 Apr; 1(4):377-9. PubMed ID: 3499543
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Comparison of fluorochrome-labeled and 51Cr-labeled targets for natural killer cytotoxicity assay.
    Wierda WG; Mehr DS; Kim YB
    J Immunol Methods; 1989 Aug; 122(1):15-24. PubMed ID: 2760476
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Assessment of human natural killer and lymphokine-activated killer cell cytotoxicity against Toxoplasma gondii trophozoites and brain cysts.
    Dannemann BR; Morris VA; Araujo FG; Remington JS
    J Immunol; 1989 Oct; 143(8):2684-91. PubMed ID: 2477453
    [TBL] [Abstract][Full Text] [Related]  

  • 49. T cells and natural killer cells after treatment of hairy cell leukaemia with 2-chlorodeoxyadenosine.
    Schirmer M; Hilbe W; Geisen F; Thaler J; Konwalinka G
    Acta Haematol; 1997; 97(3):180-3. PubMed ID: 9066714
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Heterogeneity within the population of NK and K cells.
    Jensen PJ; Koren HS
    J Immunol; 1980 Jan; 124(1):395-8. PubMed ID: 6985645
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Surface markers and cytotoxic activity of blood natural killer cells studied at the single cell level in Hodgkin's disease.
    Jezewska E; Björkholm M; Giscombe R; Holm G; Tullgren O
    Clin Exp Immunol; 1985 Jul; 61(1):96-102. PubMed ID: 4042422
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Deficiency of natural killer cell activity in patients with chronic lymphocytic leukemia.
    Ziegler HW; Kay NE; Zarling JM
    Int J Cancer; 1981 Mar; 27(3):321-7. PubMed ID: 6169660
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Mechanisms of diminished natural killer cell activity in pregnant women and neonates.
    Baley JE; Schacter BZ
    J Immunol; 1985 May; 134(5):3042-8. PubMed ID: 3980989
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The use of non-radioactive chromium as an alternative to 51Cr in NK assay.
    Borella P; Bargellini A; Salvioli S; Medici CI; Cossarizza A
    J Immunol Methods; 1995 Oct; 186(1):101-10. PubMed ID: 7561139
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Natural killer activity from normal peripheral blood lymphocytes against a human T lymphotropic retrovirus type III (HTLV-III)-infected cell line.
    Sirianni MC; De Sanctis G; Macchi B; Soddu S; Ensoli F; Aiuti F; Fontana L
    Diagn Clin Immunol; 1988; 5(6):297-303. PubMed ID: 3219779
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Recycling and target binding capacity of human natural killer cells.
    Ullberg M; Jondal M
    J Exp Med; 1981 Mar; 153(3):615-28. PubMed ID: 7252409
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Deficiency of active natural killer cells in the Chediak-Higashi syndrome. Localization of the defect using a single cell cytotoxicity assay.
    Katz P; Zaytoun AM; Fauci AS
    J Clin Invest; 1982 Jun; 69(6):1231-8. PubMed ID: 6177715
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Abnormal natural killer cell activity in systemic lupus erythematosus: an intrinsic defect in the lytic event.
    Katz P; Zaytoun AM; Lee JH; Panush RS; Longley S
    J Immunol; 1982 Nov; 129(5):1966-71. PubMed ID: 7119439
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Development and functional characterization of monoclonal antibodies recognizing chicken lymphocytes with natural killer cell activity.
    Chung KS; Lillehoj HS
    Vet Immunol Immunopathol; 1991 Jul; 28(3-4):351-63. PubMed ID: 1659030
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [The effect of sera of breast cancer patients on NK cell activity].
    Konjević G; Spuzić I
    Srp Arh Celok Lek; 1995; 123(9-10):227-31. PubMed ID: 17974436
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.